Compounds > fibrinogen
Page last updated: 2024-08-26

fibrinogen and Hyperlipoproteinemia Type IV

fibrinogen has been researched along with Hyperlipoproteinemia Type IV in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belloni, M; Calabrò, A; Crepaldi, G; Muggeo, M; Ongaro, G1
Pschierer, V; Richter, WO; Schwandt, P1
Avellone, G; Bompiani, GD; Cordova, R; De Simone, R; Di Garbo, V; Raneli, G1
Minkenberg, R; Otto, C; Richter, WO; Ritter, MM; Schwandt, P1
Katschnig, H; Pogglitsch, H; Pristautz, H; Sailer, S; Schenk, H; Steinberger, R1
Deck, C; Huster, G; Radack, K1

Trials

2 trial(s) available for fibrinogen and Hyperlipoproteinemia Type IV

ArticleYear
Primary chylomicronemia in patients with severe familial hypertriglyceridemia responds to long-term treatment with (n-3) fatty acids.
    The Journal of nutrition, 1995, Volume: 125, Issue:6

    Topics: Adult; Aged; Body Weight; Cholesterol; Chylomicrons; Dose-Response Relationship, Drug; Fatty Acids, Omega-3; Female; Fibrinogen; Food, Fortified; Humans; Hyperlipoproteinemia Type IV; Lipids; Lipoproteins; Male; Middle Aged; Triglycerides

1995
The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic subjects.
    Journal of the American College of Nutrition, 1990, Volume: 9, Issue:4

    Topics: Corn Oil; Dietary Fats; Double-Blind Method; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Fibrinogen; Fish Oils; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Randomized Controlled Trials as Topic

1990

Other Studies

4 other study(ies) available for fibrinogen and Hyperlipoproteinemia Type IV

ArticleYear
[Blood hyperviscosity syndromes].
    La Ricerca in clinica e in laboratorio, 1983, Volume: 13 Suppl 3

    Topics: Blood Pressure; Blood Viscosity; Fibrinogen; Hematologic Diseases; Humans; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Immunoglobulins; Lipids; Lipoproteins, VLDL; Multiple Myeloma; Syndrome; Ultrafiltration; Waldenstrom Macroglobulinemia

1983
Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1993, Volume: 4, Issue:3

    Topics: Adult; Apolipoproteins; Constriction; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipoproteinemia Type IV; Lipids; Male; Middle Aged; Plasminogen; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Veins

1993
Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Metabolism: clinical and experimental, 2001, Volume: 50, Issue:2

    Topics: Arteriosclerosis; Blood Viscosity; Cross-Sectional Studies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Risk Factors

2001
[Effect of various parameters on heparin utilization in short-term hemodialysis].
    Die Medizinische Welt, 1979, Dec-07, Volume: 30, Issue:49

    Topics: Acidosis; Adult; Age Factors; Alkaline Phosphatase; Blood Coagulation Tests; Dose-Response Relationship, Drug; Female; Fibrinogen; gamma-Glutamyltransferase; Heparin; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type IV; L-Lactate Dehydrogenase; Lipoproteins, VLDL; Male; Middle Aged; Platelet Count; Renal Dialysis

1979